Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

New therapeutic protein reduces B-cell signaling

May 3, 2019

Pericytes rebuild muscle mass

May 3, 2019

FDA approves etanercept biosimilar Eticovo

April 30, 2019

FDA approves intravenous Benlysta for pediatric SLE

April 29, 2019

Discovery of novel selective hematopoietic prostaglandin D synthase inhibitors

April 29, 2019

Strengthening muscle cell production

April 25, 2019

Vicore to develop VP-01 for diffuse systemic sclerosis

April 23, 2019

Phase III COAST-X study of Taltz in nonradiographic axial spondyloarthritis meets key endpoints

April 23, 2019

Shanghai Synergy Pharmaceutical Sciences, Zhejiang Huahai Pharmaceutical patent JAK inhibitors

April 17, 2019

Potential new regenerative strategy identified for OA

April 15, 2019

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....